Saudi Steel Pipe subsidiary wins $243mln order for Aramco's carbon capture project
The company said in a stock exchange statement that the LSAW pipes are for Aramco's Accelerated Carbon Capture & Storage (CCS) hub project in Jubail in the Eastern Province.
The duration of the contract is up to 15 months, the statement noted.
In December 2024, Aramco had signed a shareholders' agreement with Linde, the world's largest industrial gases company, and top oilfield services firm SLB to set up one of the world's largest carbon capture and storage (CCS) hubs in Jubail.
Phase 1 of the CCS will capture and store up to nine million metric tonnes per annum (MMtpa) of CO2 from three Aramco gas plants and other industrial sources, and is set to be completed by the end of 2027.
(Writing by Anoop Menon; Editing by SA Kader)
(anoop.menon@lseg.com)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
3 hours ago
- Zawya
INTERVIEW: Strong Q2 results underscore strategy shift to complex care
Burjeel Holdings, the ADX-listed super-specialty healthcare provider, reported strong second-quarter results with net profit more than doubling and revenue rising nearly 19 percent year-on-year, driven by higher patient volumes and continued expansion in specialty services. In an interview with Zawya Projects, CEO John Sunil said the second quarter performance validated the group's strategy of investing in complex care areas such as oncology, women's health, and surgical specialties. 'The second quarter was strong for us, both in terms of results and execution,' Sunil said. 'We saw strong momentum in complex care, particularly in oncology, women's health, and surgical specialties.' The healthcare group has been expanding its regional footprint with new specialty centres in Dubai, Sharjah, Al Ain, and Oman, along with strategic acquisitions such as the Advanced Care Oncology Centre and a major rehabilitation facility in Riyadh. Despite deploying 403 million UAE dirhams in capital investments in the first half of 2025, Burjeel maintained a stable balance sheet and a 47 percent dividend payout, reflecting strong cash flows. The company reaffirmed its mid-teens revenue growth guidance for FY2025, with UAE and Saudi operations expected to anchor growth, while expansion into emerging markets like Africa will follow an asset-light Operations and Maintenance (O&M) model. Excerpts from the interview: What drove the strong Q2 performance and margin gains? We recorded 19 percent revenue growth and more than doubled our net profit, which was driven by operating leverage and better optimisation of our asset base. We have been very intentional about building a performance-driven culture. Even with 143 new physicians on boarded over the past year, we managed to optimise personnel costs through better workforce planning and scheduling. In fact, overheads came down by seven percent compared to the previous quarter and over 13 percent compared to Q4 last year. These improvements in cost control, combined with the top-line growth, led to a significant improvement in EBITDA margins. What's the strategy behind your mental health and rehab platforms? We believe in building a truly integrated model of care. With Alkalma, we are building a comprehensive mental health platform that has already launched four centres across the UAE and Saudi Arabia. Demand has been robust and continues to grow across different age groups. Similarly, our PhysioTherabia network in Saudi Arabia has grown to over 30 centres, supported by long-term government contracts. These platforms allow us to offer preventive, supportive, and recovery-oriented services that reduce the burden on acute care systems and improve overall outcomes. With the AED 170 million acquisition of Medeor Hospital's Dubai building, how does asset ownership support Burjeel's long-term strategic and financial goals? Owning the Medeor Hospital building in Dubai was a strategic move. It eliminated a long-term lease, gave us full operational control, and converted a high-performing facility into a capital asset. That translates directly into financial flexibility and cost efficiency. This investment also reflects our long-term commitment to Dubai as a strategic market. Could you share insights into your capital allocation strategy? Our capital allocation is guided by impact and long-term value. We're not just adding facilities - we're scaling services that meet clear clinical needs and deliver returns. Whether expanding oncology care, launching the Trust Fertility platform, or extending access to primary care, each investment aligns with our core strategy. At the same time, we are maintaining financial discipline. Free cash flow conversion improved significantly, and our debt remains well within manageable levels. We are focused on ensuring that each new asset is launched efficiently and begins contributing at its full potential. Expansion is important, but we are equally focused on execution and cost discipline. What are your expectations for the rest of FY2025? We are optimistic about the rest of the year. Many of our newly launched assets are starting to scale up. As utilisation improves, we expect continued margin improvement. We continue to target mid-teens revenue growth for the full year, supported by ongoing expansion in the UAE and Saudi Arabia. Our priorities remain clear on enhancing efficiency, deepening our subspecialty platforms, and scaling services through our core network and partnerships - particularly in high-impact areas such as oncology, transplant, fertility, orthopedics, and neuroscience. It is important to remember that major investments in specialised care and technology take time to translate into full financial returns. But this quarter shows that our strategy is beginning to deliver real value. How do you balance shareholder returns with reinvestment needs? We are committed to delivering value to our shareholders while ensuring the business is well-positioned for long-term growth. The 47 percent payout ratio reflects that balance. It rewards shareholders and preserves the flexibility we need to keep investing in our platform. As we continue to scale, we are open to exploring alternative funding instruments such as Sukuk, provided they align with our financial and strategic goals. But we will remain measured in our approach and focused on ensuring any capital raised is used for initiatives that create sustainable value. With rising rates, pricing pressures, and tighter regulation across MENA, how is Burjeel navigating this challenging operating environment? We are navigating this environment by staying agile and focusing on efficiency. Our diverse portfolio, which includes facilities across the UAE, Saudi Arabia, and Oman, and our mix of public and private contracts, provides us with a degree of resilience. We are also making meaningful progress in digital transformation. With tools like Oracle EMR and AI-based diagnostics, we are gaining better visibility across the system and improving both clinical and operational performance. This helps us manage costs and also positions us well for outcome-based reimbursement models, which are becoming more important in this regulatory landscape. Amid macro headwinds and expansion, how confident are you in meeting your FY2025 growth target? Yes, we are confident in our growth target. The strong performance in the first half gives us a solid platform. With many new centres coming online and strong demand for complex care, we expect momentum to continue into the second half. The UAE remains our largest and most mature market, particularly in high-acuity specialties. A great example is Trust Fertility Centre, now the largest of its kind in the country. It broke even within six months, treated over 1,800 patients, and delivered outcomes above global benchmarks. This type of replicable, high-impact model supports both our growth ambitions and our commitment to clinical excellence. Saudi Arabia continues to be a key growth engine. We are scaling our PhysioTherabia network and preparing to launch day surgery platforms. In emerging markets like Africa, we are exploring opportunities strictly through asset-light, zero-capex Operations and Management (O&M) partnerships. This allows us to expand our presence efficiently, without balance sheet exposure, while capturing growth opportunities across the regions. (Reporting by SA Kader; Editing by Anoop Menon) (
Zawya
4 hours ago
- Zawya
Saudi EXIM enters deal with Shelter Afrique to support development projects
The Saudi Export-Import Bank (Saudi EXIM) has signed a memorandum of understanding (MoU) with Shelter Afrique to support housing, infrastructure, and urban development projects in African countries and to explore joint financing opportunities aligned with the development goals of both parties. The MoU was signed by CEO of Saudi EXIM Bank Eng Saad Al-Khalb and Managing Director of Shelter Afrique Thierno-Habib Hann in Nairobi, the capital of Kenya, during the bank's official delegation visit aimed at strengthening cooperation with financial institutions and international organizations, and enabling Saudi non-oil exports in African markets, said a Saudi Press Agency report. Al-Khalb said: 'The MoU with Shelter Afrique is a significant step toward expanding financial and investment cooperation in urban development and infrastructure projects. It also contributes to developing innovative financing solutions that support sustainable development efforts across the African continent and open opportunities for local companies and exporters to actively participate in promising development projects.' He affirmed that the MoU is an extension of the bank's efforts to enhance international cooperation and expand strategic partnerships with African institutions, in support of Saudi non-oil exports and their competitiveness in global markets. During the visit, Al-Khalb met with Cabinet Secretary for Investments, Trade, and Industry of the Republic of Kenya Lee Kinyanjui, and discussed ways to enhance bilateral cooperation and increase the flow of Saudi exports to Kenya. He also held a series of meetings with leaders of financial and insurance institutions, as part of the bank's efforts to expand its international partnerships and reinforce trade relations, said the report. Copyright 2025 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (
Gulf Today
18 hours ago
- Gulf Today
Adnoc Distribution delivers strong H1 2025 results with 12% net profit growth
ADNOC Distribution today reported double-digit growth in its EBITDA and net profit for the first half of 2025. The company achieved its highest-ever first-half EBITDA of $566 million, up 10.0 percent year-on-year (YoY), driving a 12.2 per cent YoY increase in net profit to $358 million. The company also achieved record first-half fuel volumes of 7.62 billion litres, up 5.6 per cent YoY. Bader Saeed Al Lamki, CEO of ADNOC Distribution, said, 'Our strong H1 2025 results demonstrate the successful execution of our 2024-28 growth strategy, driven by operational excellence and customer-focused innovation. The sustained growth in EBITDA and net profit highlights our ability to scale effectively, drive value creation, and expand our leadership in mobility and convenience retail. "By leveraging advanced technologies, unlocking new operational efficiencies, and bringing our commitment to quality to more communities than ever before, we are well-positioned to deliver sustainable, long-term growth and superior returns for our shareholders.' ADNOC Distribution's non-fuel retail business continues to drive strong growth, with a 14.9 per cent YoY increase in non-fuel retail gross profit and a 10.4 per cent YoY rise in transactions for the first half of 2025. This continued outperformance of non-fuel retail over fuel retail reinforces the company's strategic focus on diversifying revenue streams and capturing growing demand for convenience services. In addition, ADNOC Rewards, the UAE's leading fuel and convenience loyalty program, grew by 19.5 per cent YoY to nearly 2.5 million users. ADNOC Distribution continued its strategic network expansion, adding 47 new service stations in the first half of 2025, bringing its total network to nearly 940. A majority of the new stations are located in Saudi Arabia, where the company is successfully leveraging its CAPEX-light Dealer Owned-Company Operated (DOCO) business model, which is optimised for sustainable growth. The DOCO model has enabled ADNOC Distribution to double its Saudi network YoY, from 69 to 140 stations. Building on this momentum, the company has revised its expansion guidance upwards to 60-70 new stations by the end of 2025, with 50-60 of these located in Saudi Arabia. In May 2025, ADNOC Distribution launched the Voyager lubricant line nationally across Egypt, expanding its distribution to third-party retail stores for the first time. The company has set a target of 3,000 points of sale in Egypt by the end of 2026. Additionally, ADNOC Distribution's E2GO fast- and super-fast EV charging network reached a significant milestone in H1 2025, with over 300 charging points now installed across the UAE. It also targets the growing of its network to over 500 charging points by 2028. The company is on track to meet its target of adding 100 new charging points in 2025. As part of its digital transformation, ADNOC Distribution deployed MEERAi, ADNOC's AI-powered board advisory tool, at its most recent Board meeting. Designed for executive use, MEERAi delivers real-time insights, enabling faster, data-driven decisions. With robust net debt to EBITDA ratio of 0.80x at the end of H1 2025, the company remains committed to its dividend policy, ensuring clear visibility on returns. ADNOC Distribution expects an annual payout of $700 million (at 20.57 fils per share) or a minimum of 75 percent of net profit, whichever is higher, through 2028. At a share price of 3.70 as of 6th August 2025, this represents an annual yield of nearly 6 percent. A dividend of $350 million for H1 2025 is expected to be distributed in October 2025, subject to Board approval. WAM
